Lymphocyte‐C‐reactive protein ratio as a novel prognostic index in intrahepatic cholangiocarcinoma: A multicentre cohort study

Clinical presentation, diagnosis and staging of cholangiocarcinoma

(2019) Alejandro Forner et al.   LIVER INTERNATIONAL

Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer

(2019) Yoshinaga Okugawa et al.   ANNALS OF SURGERY

Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer

(2019) Yoshinaga Okugawa et al.   CLINICAL NUTRITION

Platelet-albumin-bilirubin grade: Risk stratification of liver failure, prognosis after resection for hepatocellular carcinoma

(2019) Liang-He Lu et al.   DIGESTIVE AND LIVER DISEASE

Prognostic comparison of the 7th and 8th editions of the American Joint Committee on Cancer staging system for intrahepatic cholangiocarcinoma

(2018) Sang-Hyun Kang et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Comparative performances of the 7th and the 8th editions of the American Joint Committee on Cancer staging systems for intrahepatic cholangiocarcinoma

(2017) Gaya Spolverato et al.   JOURNAL OF SURGICAL ONCOLOGY

Staging of intrahepatic cholangiocarcinoma

(2017) Sean M. Ronnekleiv-Kelly et al.   HEPATOBILIARY SURGERY AND NUTRITION

Prognostic Role of Platelet to Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis

(2014) A. J. Templeton et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

(2014) John Bridgewater et al.   JOURNAL OF HEPATOLOGY

A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)

(2012) D J Pinato et al.   BRITISH JOURNAL OF CANCER

The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer

(2012) Donald C. McMillan   CANCER TREATMENT REVIEWS

Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma

(2012) Wolfgang Sieghart et al.   HEPATOLOGY

Use of Inflammatory Markers to Guide Cancer Treatment

(2011) S J Clarke et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study

(2011) Michael J. Proctor et al.   EUROPEAN JOURNAL OF CANCER

The relationship among acute-phase responce proteins, cytokines, and hormones in various gastrointestinal cancer types patients with cachectic

(2011) O Kemik et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment

(2011) Mechteld C. de Jong et al.   JOURNAL OF CLINICAL ONCOLOGY

The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer

(2010) G. Kasymjanova et al.   Current Oncology

Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients

(2010) Zhi-Qing Yang et al.   HUMAN IMMUNOLOGY

Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma

(2010) Gaspar Reynés et al.   JOURNAL OF NEURO-ONCOLOGY

Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

(2009) Isabelle Ray-Coquard et al.   CANCER RESEARCH

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

(2009) F. Colotta et al.   CARCINOGENESIS